Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000119
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0859
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.544
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lipase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lipase
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
9.44×10-07
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0431
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.413
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.694
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0419
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0115
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Creatinine
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.0316
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, including Weight
|
6.67×10-10
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00611
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0138
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.140
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.577
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0838
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.209
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00629
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0566
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.396
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.739
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0121
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00608
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.223
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / UIBC (unsaturated iron binding capacity)
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0336
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.400
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.210
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
4.34×10-05
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.755
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.951
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
580f:576m
|
|
|
NotProcessed |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Carbon dioxide production
|
HOM
|
441f:441m
|
|
|
NotProcessed |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.421
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.672
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Oxygen consumption
|
HOM
|
441f:441m
|
|
|
NotProcessed |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0523
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.137
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
8.94×10-05
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
441f:441m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0112
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Dysmorphology / fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
2.75×10-09
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0200
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
580f:576m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0106
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.493
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.167
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.386
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00866
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00832
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.607
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000299
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00477
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00788
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.198
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000117
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Total food intake
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.254
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00128
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0500
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.511
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.705
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.218
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.975
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.386
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.979
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.454
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.537
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000529
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00127
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.695
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
580f:576m
|
|
|
NotProcessed |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0312
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
6f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.838
|
Successful |
Rxfp2tm1a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.286
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HOM
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.322
|
Successful |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Rxfp2tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
5f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.845
|
Successful |